万春药业

BYSI

全部股东

股东类型

  • 公众及其他70.92%
  • 个人与内部人士13.06%
  • 风投/私募9.24%
  • 机构投资者6.78%

主要股东

主要股东 最新
股东
Lan HuangCo-Founder & Chair of the Board
12.87%529.34 万<0.01%-4.00
Decheng Capital LLC
9.24%380.07 万0.00%+0
Vanguard Capital Management, LLC
1.96%80.77 万0.05%+1.98 万
BlackRock, Inc.
1.64%67.29 万0.06%+2.35 万
Sincere Efforts Foundation Inc
1.20%49.45 万0.00%+0
Geode Capital Management, LLC
0.89%36.77 万0.02%-7,631.00
State Street Investment Management
0.56%23.11 万0.00%+0
UBS Asset Management AG
0.15%6.30 万0.15%+6.19 万
Northern Trust Global Investments
0.15%6.20 万0.02%-7,244.00
Jiangwen MajetiIndependent Vice Chairman
0.12%5.09 万0.00%+0
Tanaka Capital Management Inc
0.06%2.63 万0.00%+0
Patrick FabbioIndependent Director
0.06%2.46 万0.00%+0
Meridian Wealth Management, LLC
0.04%1.50 万0.00%+0
Farther Finance Advisors, LLC
0.03%1.28 万--+1.28 万
Renaissance Technologies LLC
0.03%1.09 万<0.01%-200.00
Lord, Abbett & Co. LLC
0.02%7,272.00<0.01%+1,233.00
Vanguard Global Advisers, LLC
0.01%4,802.000.00%+0
Morgan Stanley
<0.01%4,000.000.00%+0
National Bank Investments Inc.
<0.01%2,875.000.00%+0
Trifecta Capital Advisors, LLC
<0.01%1,500.000.00%+0